Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
- PMID: 34446507
- DOI: 10.1183/13993003.02008-2021
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
Conflict of interest statement
Conflict of interest: D.G. Kiely reports grants, personal fees and funds for meeting attendance from Janssen and GSK, personal fees and funds for meeting attendance from MSD, personal fees from Acceleron, outside the submitted work. Conflict of interest: R. Condliffe reports personal fees and funds for meeting attendance from Janssen, GSK and MSD, outside the submitted work.
Comment on
-
Elevated pulmonary vascular resistance predicts mortality in COPD patients.Eur Respir J. 2021 Aug 26;58(2):2100944. doi: 10.1183/13993003.00944-2021. Print 2021 Aug. Eur Respir J. 2021. PMID: 33986032 No abstract available.
-
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry.Eur Respir J. 2021 Aug 26;58(2):2101483. doi: 10.1183/13993003.01483-2021. Print 2021 Aug. Eur Respir J. 2021. PMID: 34385266 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical